{"organizations": [], "uuid": "9ccc63d4934618e0048baee668cf48628b8054a9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-beckman-coulter-diagnostics-announ/brief-beckman-coulter-diagnostics-announces-worldwide-commercialization-of-the-access-sensitive-estradiol-idUSFWN1RN0O8", "country": "US", "domain_rank": 408, "title": "BRIEF-Beckman Coulter Diagnostics Announces Worldwide Commercialization Of The Access Sensitive Estradiol", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-10T18:45:00.000+03:00", "replies_count": 0, "uuid": "9ccc63d4934618e0048baee668cf48628b8054a9"}, "author": "", "url": "https://www.reuters.com/article/brief-beckman-coulter-diagnostics-announ/brief-beckman-coulter-diagnostics-announces-worldwide-commercialization-of-the-access-sensitive-estradiol-idUSFWN1RN0O8", "ord_in_thread": 0, "title": "BRIEF-Beckman Coulter Diagnostics Announces Worldwide Commercialization Of The Access Sensitive Estradiol", "locations": [], "entities": {"persons": [{"name": "beckman coulter", "sentiment": "none"}, {"name": "beckman coulter", "sentiment": "none"}], "locations": [], "organizations": [{"name": "coulter diagnostics", "sentiment": "negative"}, {"name": "brief-beckman coulter diagnostics", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "access sensitive estradiol reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 10, 2018 / 3:48 PM / Updated 11 minutes ago BRIEF-Beckman Coulter Diagnostics Announces Worldwide Commercialization Of The Access Sensitive Estradiol Reuters Staff 1 Min Read \nApril 10 (Reuters) - Beckman Coulter Diagnostics: \n* BECKMAN COULTER DIAGNOSTICS ANNOUNCES WORLDWIDE COMMERCIALIZATION OF THE ACCESS SENSITIVE ESTRADIOL Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-10T18:45:00.000+03:00", "crawled": "2018-04-10T19:05:04.030+03:00", "highlightTitle": ""}